Brian Nowosielski

Check out this recap of articles published on our sister sites during the past week.

Tom DePietro, PharmD, owner of DePietro’s Pharmacy in Dunmore, Pennsylvania, discussed his experience as an independent pharmacy owner working under the thumb of pharmacy benefit managers.

The partnership’s revolutionary new product is set to premiere at the National Association of Chain Drug Stores’ Total Store Expo in Boston, Massachusetts, kicking off on August 17, 2024.

New prices will go into effect on January 1, 2026, for individuals covered by Medicare Part D prescription drugs.

Tom DePietro, PharmD, owner of DePietro’s Pharmacy in Dunmore, Pennsylvania, talked about current movement toward PBM reform and his hopes for the future of pharmacy.

Experts analyzed data from the National Center for Health Statistics on the leading causes of death in the US from the last 5 years.

Tom DePietro, PharmD, owner of DePietro’s Pharmacy in Dunmore, Pennsylvania, shared his thoughts on how patients are treated within the drug supply chain.

Tom DePietro, PharmD, owner of DePietro’s Pharmacy in Dunmore, Pennsylvania, discussed the current state of independent pharmacy and the role pharmacy benefit managers play within the supply chain.

Check out this recap of articles published on our sister sites during the past week.

A cohort study was conducted to address the association between patients with cannabis-related disorders and their risk of developing head and neck cancer.

Researchers addressed the difference between prescribing guselkumab doses every 16 weeks and every 8 weeks for super responder patients with moderate to severe psoriasis.

Researchers conducted a systematic review of literature exploring the misuse of opioid prescriptions for patients with chronic non-cancer pain.

Researchers tested various text-to-image generation platforms to better understand issues of representation within artificial intelligence.

See what’s trending in pharmacy with a preview of the Total Pharmacy August issue.

J.D. Power released a report detailing the change in mail-order and retail pharmacy trends from 2023 to 2024.

Check out this recap of articles published on our sister sites during the past week.

Researchers aimed to discover whether pharmacist-led delivery of oral anticoagulation therapy can lead to an increase in stroke risk reduction for patients with actionable atrial fibrillation.

Researchers aimed to address the association of all-cause dementia risk and 3 separate chronicities of anxiety.

Catch up on important immunization news from the month of July.

Researchers aimed to address the change in trust individuals exhibited regarding US physicians and hospitals during the COVID-19 pandemic.

CVS Caremark and the State of Illinois settled a lawsuit due to the company’s failure to pay contracted rebates.

Researchers analyzed the prominence of opioid and methadone prescriptions for hospitalized newborns with substantial morbidities.

Erin Albert, Vice President of Pharmacy Relations and Chief Privacy Officer at Mark Cuban Cost Plus Drug Company, PBC, discussed the changing landscape regarding prescription drug pricing.

Jon Minkin, Enterprise Account Executive at NimbleRx and pharmacy technology expert, discussed how his company can help independent pharmacies unlock revenue opportunities.

Check out this recap of articles published on our sister sites during the past week.

Researchers aimed to address the associations between prenatal cannabis use and maternal health outcomes over a 9-year period.

The American College of Allergy, Asthma, and Immunology (ACAAI) recently released its 5 tips to help children and their parents stay educated on asthma peak month.

In a House Committee on Oversight and Accountability hearing, Democrats and Republicans took a bipartisan stance to question the role major PBMs play regarding rising drug costs in the US.

A survey conducted by Surescripts, a health care solutions company, explored the attitudes of pharmacists and prescribers towards ongoing issues and challenges currently facing the industry.

Industry experts explored the increase in US prescription drug spending and how state spending targets come into play regarding patients’ rising out-of-pocket costs.